UOS Integrazione Cure Primarie e Specialistiche

Milano, Italy

UOS Integrazione Cure Primarie e Specialistiche

Milano, Italy

Time filter

Source Type

Musacchio N.,UOS Integrazione Cure Primarie e Specialistiche | Lovagnini Scher A.,UOS Integrazione Cure Primarie e Specialistiche | Giancaterini A.,UOS Integrazione Cure Primarie e Specialistiche | Pessina L.,UOS Integrazione Cure Primarie e Specialistiche | And 2 more authors.
Diabetic Medicine | Year: 2011

Aims Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano-Milanino diabetes clinic, patients with Type2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1c without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently. Methods Clinical outcomes measured in the year before and after the initiation of SINERGIA were compared. A generalized hierarchical linear regression model for repeated measures was used. Results Altogether, 1004 patients were included; baseline characteristics were (mean±sd): age 66.6±6.2years, 54.1% male, diabetes duration 10.8±7.7years, BMI 29.5±4.8kg/m2, HbA1c 6.9±0.9% (52±14mmol/mol); 72.9% of patients were treated with anti-hypertensive drugs; 32.7% were treated with lipid-lowering drugs. After a median follow-up of 12months (range 6-24months), the proportion of patients with HbA1c≤7.0% (≤53mmol/mol) increased from 32.7 to 45.8% (P<0.0001), while those with HbA1c≥9% (≥75mmol/mol) decreased from 10.5 to 4.3% (P<0.0001). Patients with LDL cholesterol <100mg/dl (<2.59mmol/l) increased from 40 to 47% (P<0.0001), while those with LDL cholesterol ≥130mg/dl (≥3.36mmol/l) decreased from 26.6 to 19.7%; blood pressure levels were slightly improved. The mean number of face-to-face encounters decreased from (median and range) 2.8 (2.3-3.4) to 2.3 (1.9-2.7) (P<0.0001) visits per patient/year. Conclusions The SINERGIA model is effective in improving metabolic control and major cardiovascular risk factors, while allowing diabetologists to dedicate more time to patients with more acute disease. © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.


PubMed | UOS Integrazione Cure Primarie e Specialistiche
Type: Evaluation Studies | Journal: Diabetic medicine : a journal of the British Diabetic Association | Year: 2011

Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano-Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA(1c) without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently.Clinical outcomes measured in the year before and after the initiation of SINERGIA were compared. A generalized hierarchical linear regression model for repeated measures was used.Altogether, 1004 patients were included; baseline characteristics were (mean sd): age 66.6 6.2 years, 54.1% male, diabetes duration 10.8 7.7 years, BMI 29.5 4.8 kg/m(2) , HbA(1c) 6.9 0.9% (52 14 mmol/mol); 72.9% of patients were treated with anti-hypertensive drugs; 32.7% were treated with lipid-lowering drugs. After a median follow-up of 12 months (range 6-24 months), the proportion of patients with HbA(1c) 7.0% ( 53 mmol/mol) increased from 32.7 to 45.8% (P<0.0001), while those with HbA(1c) 9% (75 mmol/mol) decreased from 10.5 to 4.3% (P<0.0001). Patients with LDL cholesterol <100 mg/dl (<2.59 mmol/l) increased from 40 to 47% (P <0.0001), while those with LDL cholesterol 130 mg/dl (3.36 mmol/l) decreased from 26.6 to 19.7%; blood pressure levels were slightly improved. The mean number of face-to-face encounters decreased from (median and range) 2.8 (2.3-3.4) to 2.3 (1.9-2.7) (P<0.0001) visits per patient/year.The SINERGIA model is effective in improving metabolic control and major cardiovascular risk factors, while allowing diabetologists to dedicate more time to patients with more acute disease.

Loading UOS Integrazione Cure Primarie e Specialistiche collaborators
Loading UOS Integrazione Cure Primarie e Specialistiche collaborators